InnovaRx Innova Health Strategies
PricingSign in

D68.32

Bookmark

Hemorrhagic disorder due to extrinsic circulating anticoagulants

Filed alongside this entry 305

under Disorder (of)

Index entries, exactly as the book files them. This says they are listed together — not that any of them is documented in your chart.

Billable FY2027 2026-10-01 → 2027-09-30
How to use this page

Everything the published sources say about one code, on one page.

  1. Read the Excludes1 block first — it is the one that stops you coding this at all alongside another code.
  2. Excludes2, Code first, Use additional and Includes follow. A note inherited from a parent category is labelled with the category it came from, so you can see why it applies.
  3. Official Guidelines sit below. "Guidelines naming this code" cite the code or a range containing it; "Chapter guidance" is the general guidance for its chapter and is the weaker signal.
  4. Guideline text is quoted verbatim with its section number and page, so you can check it against the published document.
  5. Risk-model chips show which published CMS models map this code.

What this page does not do

  • Guidance is quoted, never paraphrased — a paraphrase of a coding rule is a different rule.
  • Medication candidates, where shown, are matched by condition *name* and are offered as candidates for you to judge. They are not "the drugs for this code".

All page guides →

Exclusions12never code together
D68code
Excludes1
  • abnormal coagulation profile NOS (R79.1)R79.1
Excludes2
  • coagulation defects complicating abortion or ectopic or molar pregnancy (O00-O07, O08.1)O00-O07O08.1
  • coagulation defects complicating pregnancy, childbirth and the puerperium (O45.0, O46.0, O67.0, O72.3)O45.0O46.0O67.0O72.3
D50-D89chapter
Excludes2
  • autoimmune disease (systemic) NOS (M35.9)M35.9
  • certain conditions originating in the perinatal period (P00-P96)P00-P96
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)O00-O9A
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)Q00-Q99
  • endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
  • human immunodeficiency virus [HIV] disease (B20)B20
  • injury, poisoning and certain other consequences of external causes (S00-T88)S00-T88
  • neoplasms (C00-D49)C00-D49
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)R00-R94

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes5
D68.32code
Inclusion terms
  • Drug-induced hemorrhagic disorder
  • Hemorrhagic disorder due to increase in anti-IIa
  • Hemorrhagic disorder due to increase in anti-Xa
  • Hyperheparinemia
Use additional code
  • code for adverse effect, if applicable, to identify drug (T45.515, T45.525)T45.515T45.525
Official Guidelines1names this code

ICD-10-CM Official Guidelines for Coding and Reporting, quoted in full. Published by CMS and NCHS; in the public domain.

I.C.3 Chapter 3: Disease of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) names this code p.39

Reserved for future guideline expansion

Index entries leading here4
  • Anticoagulant, circulating (intrinsic) D68.318
  • Disorder (of) — see also Disease
  • Circulating anticoagulants D68.318
  • Hyperheparinemia D68.32
Alongside this code1same parent — D68.3
D68.31 Hemorrhagic disorder due to intrns circ anticoag,antib,inhib category
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS22HCC48 ESRD21HCC48 ESRD24HCC48 HHS08HHS_HCC075

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2027
Parent
D68.3
Block
D65-D69
Siblings
1

Present FY2018–FY2027.